10.46243/jst.2021.v6.i2.pp01-08 registered
Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects
Resolves to https://www.jst.org.in/index.php/pub/article/view/356
Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i2.pp01-08
Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 cfdd01325a028e5d…
Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)
Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).
What the DOI identifies
JournalArticle — an article in a journal · Digital · Visual · en
Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects (PrincipalTitle · en)
Published 2021-02-02
Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 02 · pages 01–08
Agents
- Dr.A. Mohamed Sikkander (author) · ORCID 0000-0002-8458-7448
- Dr.Khadeeja Yasmeen (author)
- Longman Publishers (publisher)
Identifiers DOI 10.46243/jst.2021.v6.i2.pp01-08
Abstract · en
Nowadays, nanotechnology impacts human life every day, and the potential benefits are many and various. In contrast, due to extensive human exposure to nanoparticles, there is an important concern about the potential health and environmental risks. These concerns led to the emergence of further scientific disciplines such as nanotoxicology and nanomedicine. Nanotoxicology which is interesting in the study of potential adverse health effects of nanoparticles.While, Nanomedicine, which includes subsectors such as tissue biomaterials, engineering, biosensors, and bioimaging, was developed to study the benefits and hazards of nanomaterials that are used in medicine andmedical devices.In addition, a key promise of nanotechnology is for improved healthcare, including potentiallyrevolutionary treatments for cancer diseases (detection of cancer cells at the early stage) and improved drug delivery (such as reducing side effects), reduced inflammation, antibacterial coverings of medical devices, better surgical tissue therapeutic. However, as result to lack of reliable toxicity data, the potential to affect human health still to be a major concern.The purpose of this literature review is to contribute to a better understanding of the principles and processes the science concepts on which nanobiotechnology meansandits applications in biomedicine will be discussed as well as to their side effects.
System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1
Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.
| Element | Value | In the record |
|---|---|---|
| DOI Name DOI name | 10.46243/jst.2021.v6.i2.pp01-08 | doi |
| Referent Type referentType | Creation | referent |
| Referent Sub-Type referentSubType | JournalArticle — an article in a journal | type |
| Referent Name(s) referentName(s) | Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects (PrincipalTitle, en) | titles |
| Basic Metadata basicMetadata | author: Dr.A. Mohamed Sikkander author: Dr.Khadeeja Yasmeen publisher: Longman Publishers published: 2021-02-02 part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 02 · pp. 01–08 language: en form: Digital · Visual · Language | agents, dates, container, language, structural_type, modes, characters |
| Referent Identifier(s) alternateIdentifier(s) | none besides the DOI | identifiers, relations (IsSameAs) |
| Registration Authority registrationAuthorityCode | Crossref — issued by Crossref (member 25296); held here as a copy | record.source_agency (our code, ra_doi_name, for names issued here once appointed) |
| Created Date issueDate | 2026-09-10 | record.registered (when the DOI name was first registered) |
| relatedIdentifiers | none needed — the descriptive metadata is in this record | container, relations (only where the descriptive metadata lives at another identifier) |
complete Every System Metadata element is here, with the basic metadata a journal article needs.
The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs
Cited by — in this registry
No record held in this registry cites this DOI.
Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON
References with DOIs
The record lists 60 references; 52 carry a DOI.
| # | Reference | DOI | Held here |
|---|---|---|---|
| 3 | ref3 Lewin R. (1987). National Academy looks at human genome.Science,Feb13;235(4790). 747-8 | 10.1126/science.3468626 | not held here |
| 4 | ref4 Johnson, R. S. (1987). The human genome project: what impact on basic research?.The FASEB Journal,1(6), 502-505 | 10.1096/fasebj.1.6.3479371 | not held here |
| 5 | ref5 Yang, Z. R., & Hamer, R. (2007). Bio-basis function neural networks in protein data mining.Current pharmaceutical design, 13(14), 1403-1413 | 10.2174/138161207780765927 | not held here |
| 6 | ref6 Ahrens, C. H., Wagner, U., Rehrauer, H. K., Türker, C., &Schlapbach, R. (2007). Current challenges and approaches for the synergistic use of systems biology data in the scientific… | 10.1007/978-3-7643-7439-6_12 | not held here |
| 7 | ref7 ordan, B. R. (1999). ‘Genomics’: Buzzword or reality?Journal of biomedical science,6(3), 145-150 | 10.1007/bf02255898 | not held here |
| 8 | ref8 Weyant, R. G. (1967). Lycurgus: The father of applied psychology?American Psychologist,22(6), 432 | 10.1037/h0021069 | not held here |
| 10 | ref10 Logothetidis, S. (Ed.). (2012).Nanomedicine and nanobiotechnology. Springer Science & Business Media | 10.1007/978-3-642-24181-9 | not held here |
| 11 | ref11 Bawa, R., Audette, G. F., & Rubinstein, I. (2016).Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications. Pan Stanford | 10.1201/b19915 | not held here |
| 12 | ref12 Hulla, J. E., Sahu, S. C., & Hayes, A. W. (2015). Nanotechnology: History and future.Human & experimental toxicology,34(12), 1318- 1321 | 10.1177/0960327115603588 | not held here |
| 14 | ref14 Brown, E. M. B. (2014). Nanomedicine Advancements in Cancer Diagnosis and Treatment.Horizons in Clinical Nanomedicine, 67 | 10.1201/b15666-4 | not held here |
| 15 | ref15 Emerich DF. (2005).Nanomedicine-prospective therapeutic and diagnostic applied usages. Expert Opin. Biol. Ther, Jan;5(1). 1-5 | 10.1517/14712598.5.1.1 | not held here |
| 16 | ref16 Avti, P. K., Patel, S. C., & Sitharaman, B. (2011). Nanobiomaterials: current status and future prospects.Nanobiomaterials handbook Edited by Balaji Sitharaman. CRC publication | 10.1201/b10970-2 | not held here |
| 17 | ref17 Lee, L. A., & Wang, Q. (2006). Adaptations of nanoscale viruses and other protein cages for medical applications.Nanomedicine: Nanotechnology, Biology and Medicine,2(3), 137-149 | 10.1016/j.nano.2006.07.009 | not held here |
| 19 | ref19 Pauwels, E. K., &Erba, P. (2007). Towards the use of nanoparticles in cancer therapy and imaging.Drug news & perspectives,20(4), 213- 220 | 10.1358/dnp.2007.20.4.1103525 | not held here |
| 20 | ref20 Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005). Nanomedicine: current status and future prospects.The FASEB journal,19(3), 311-330 | 10.1096/fj.04-2747rev | not held here |
| 21 | ref21 Gulati, N., & Gupta, H. (2012). Nanomedicine: Potential devices for diagnostics.Recent Patents on Nanomedicine,2(2), 146-155. 6 | Page Review on Nanotechnology persecute vital rol… | 10.2174/1877912311202020146 | not held here |
| 23 | ref23 Dutta, R. C. (2007). Drug carriers in pharmaceutical design: promises and progress.Current pharmaceutical design,13(7), 761-769 | 10.2174/138161207780249119 | not held here |
| 24 | ref24 Dobson, J. (2006). Magnetic micro-and nano-particle-based targeting for drug and gene delivery.Nanomedicine | 10.2217/17435889.1.1.31 | not held here |
| 25 | ref25 Freitas, R. A. (2005). Nanotechnology, nanomedicine and nanosurgery.International Journal of Surgery,4(3), 243-246 | 10.1016/j.ijsu.2005.10.007 | not held here |
| 26 | ref26 Ebbesen, M., & Jensen, T. G. (2006). Nanomedicine: techniques, potentials, and ethical implications.BioMed Research International,2006 | 10.1155/jbb/2006/51516 | not held here |
| 27 | ref27 Fankhauser, F., Niederer, P. F., Kwasniewska, S., & van der Zypen, E. (2004). Supernormal vision, high-resolution retinal imaging, multiphoton imaging and nanosurgery of the corne… | 10.3233/thc-2004-12604 | not held here |
| 28 | ref28 Lamounier, J. A., Moulin, Z. S., & Xavier, C. C. (2004). Recommendations for breastfeeding during maternal infections.Jornal de pediatria, 80(5), s181-s188 | 10.2223/jped.1252 | not held here |
| 29 | ref29 Iwaki, Y., Aiba, N., Tran, H. T. T., Ding, X., Hayashi, S., Arakawa, Y., & Abe, K. (2003). Simian TT virus (s-TTV) infection in patients with liver diseases.Hepatology research,25… | 10.1016/s1386-6346(02)00250-4 | not held here |
| 31 | ref31 Filteau, S. M. (2000). Role of breast-feeding in managing malnutrition and infectious disease. Proceedings of the Nutrition Society, 59(4), 565-572 | 10.1017/s002966510000080x | not held here |
| 32 | ref32 Lawrence, R. M., & Lawrence, R. A. (2004). Breast milk and infection. Clinics in perinatology, 31(3), 501-528 | 10.1016/j.clp.2004.03.019 | not held here |
| 33 | ref33 Rajabi, M., Signorelli, P., Gorincioi, E., Ghidoni, R., &Santaniello, E. (2010). Antiproliferative activity of N 6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle an… | 10.1089/dna.2010.1073 | not held here |
| 34 | ref34 Sahoo, S. K., &Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging.Drug discovery today,8(24), 1112-1120 | 10.1016/s1359-6446(03)02903-9 | not held here |
| 35 | ref35 Smith, D. J. (2007).Characterization of nanomaterials using transmission electron microscopy. The Royal Society of Chemistry: Cambridge.1-27 | 10.1039/9781847557926-00001 | not held here |
| 36 | ref36 Angeli, E., Buzio, R., Firpo, G., Magrassi, R., Mussi, V., Repetto, L., &Valbusa, U. (2008). Nanotechnology applications in medicine.Tumori Journal, 94(2), 206-215 | 10.1177/030089160809400213 | not held here |
| 37 | ref37 Rajabi, M., Srinivasan, M., & Mousa, S. A. (2016). Nanobiomaterials in drug delivery. In Nanobiomaterials in Drug Delivery. William Andrew Publishing. 1-37 | 10.1016/b978-0-323-42866-8.00001-0 | not held here |
| 38 | ref38 Allen, T. M., & Martin, F. J. (2004, December). Advantages of liposomal delivery systems for anthracyclines. InSeminars in oncology. WB Saunders. (31), 5-15 | 10.1053/j.seminoncol.2004.08.001 | not held here |
| 39 | ref39 Freitas Jr, R. A. (2000). Nanodentistry. The Journal of the American Dental Association, 131(11), 1559-1565 | 10.14219/jada.archive.2000.0084 | not held here |
| 40 | ref40 Yao, J., Yang, M., &Duan, Y. (2014). Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnos… | 10.1021/cr200359p | not held here |
| 41 | ref41 Shan, J., &Tenhu, H. (2007). Recent advances in polymer protected gold nanoparticles: synthesis, properties and applications.Chemical Communications, (44), 4580-4598 | 10.1039/b707740h | not held here |
| 42 | ref42 Cai, W., Gao, T., Hong, H., & Sun, J. (2008). Applications of gold nanoparticles in cancer nanotechnology.Nanotechnology, science and applications, 1, 17 | 10.2147/nsa.s3788 | not held here |
| 43 | ref43 De Jong, W. H., &Borm, P. J. (2008). Drug delivery and nanoparticles: applications and hazards.International journal of nanomedicine,3(2), 133 | 10.2147/ijn.s596 | not held here |
| 44 | ref44 Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., &Medintz, I. L. (2013). Functionalizing nanoparticles with biological molecules: developing chemist… | 10.1021/cr300143v | not held here |
| 45 | ref45 Gao, J., Huang, X., Liu, H., Zan, F., & Ren, J. (2012). Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imag… | 10.1021/la204289k | not held here |
| 46 | ref46 Alexis, F., Rhee, J. W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., &Farokhzad, O. C. (2008, January). New frontiers in nanotechnology for cancer treatment. InUrologic Onco… | 10.1016/j.urolonc.2007.03.017 | not held here |
| 47 | ref47 Loos, M. (2014). Carbon nanotube reinforced composites: CNT Polymer Science and Technology. Elsevier | 10.1016/b978-1-4557-3195-4.00002-3 | not held here |
| 48 | ref48 Ju-Nam, Y and Lead, J.(2016). Properties, Sources, Pathways, and Fate of Nanoparticles in the Environment.Engineered Nanoparticles and the Environment: Biophysicochemical Processe… | 10.1002/9781119275855.ch6 | not held here |
| 49 | ref49 Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2010). Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Advanced drug delivery review… | 10.1016/j.addr.2009.11.007 | not held here |
| 50 | ref50 Zhao, Y., Gu, X., Ma, H., He, X., Liu, M., & Ding, Y. (2011). Association of glutathione level and cytotoxicity of gold nanoparticles in lung cancer cells. The Journal of Physical… | 10.1021/jp2025413 | not held here |
| 51 | ref51 Medley, C. D., Smith, J. E., Tang, Z., Wu, Y., Bamrungsap, S., & Tan, W. (2008). Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Analytical… | 10.1021/ac702037y | not held here |
| 52 | ref52 Cheng, Y., Samia, A. C., Meyers, J. D., Panagopoulos, I., Fei, B., &Burda, C. (2008). Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therap… | 10.1021/ja801631c | not held here |
| 54 | ref54 Morgan, K. (2005). Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles.Risk Analysis: An International Journal, 25(6), 1621… | 10.1111/j.1539-6924.2005.00681.x | not held here |
| 55 | ref55 Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K.,& Wood, S. (2006). Research strategies for safety evaluation of nanomaterials, part V: role of disso… | 10.1093/toxsci/kfj084 | not held here |
| 56 | ref56 Balshaw, D. M., Philbert, M., & Suk, W. A. (2005). Research strategies for safety evaluation of nanomaterials, Part III: nanoscale technologies for assessing risk and improving pu… | 10.1093/toxsci/kfi312 | not held here |
| 57 | ref57 Thomas, T., Thomas, K., Sadrieh, N., Savage, N., Adair, P., &Bronaugh, R. (2006). Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposur… | 10.1093/toxsci/kfj129 | not held here |
| 58 | ref58 Love, S. A., Maurer-Jones, M. A., Thompson, J. W., Lin, Y. S., & Haynes, C. L. (2012). Assessing nanoparticle toxicity.Annual review of analytical chemistry,5, 181-205 | 10.1146/annurev-anchem-062011-143134 | not held here |
| 59 | ref59 Lee, S. Y., & Cheng, J. X. (2010). Clearance of nanoparticles during circulation.Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, 1-32 | 10.1002/9780470571224.pse496 | not held here |
| 60 | ref60 Johnston, H. J., Semmler-Behnke, M., Brown, D. M., Kreyling, W., Tran, L., & Stone, V. (2010). Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary… | 10.1016/j.taap.2009.09.015 | not held here |
Relations
The record states no relation, and no record held here states one with this DOI.
Funding
The record names no funder.
Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.
History — the ledger
Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.
| # | When | What | By | Changes |
|---|---|---|---|---|
| 1 | 29 Sep 2026, 10:00 PM | register registered at Crossref; record read from api.crossref.org | Administrator (admin) | 231 fields set · sha256 d06f88034412… |
| 2 | 29 Sep 2026, 11:59 PM | update record re-read from api.crossref.org | Administrator (admin) | container.titles.0.value: |
Machine-readable: the history as JSON, with the full record after each change.
Changes made at Crossref through DOI Doctor
Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.
| When | What changed | Crossref | Fingerprint |
|---|---|---|---|
| 11 Sep 2026, 05:18 | Address updated from https://www.jst.org.in/index.php/pub/article/view/356/314 to https://www.jst.org.in/index.php/pub/article/view/356 | ● accepted by Crossref | bdd6ba417353… |
| 13 Sep 2026, 01:40 | Read back: the DOI resolves to the new address | ● confirmed | ab65b93f93e9… |
| 15 Oct 2026, 15:30 | Metadata completed abstract (199 words) · licence | ● accepted by Crossref | 31e5500cae54… |
| 15 Oct 2026, 16:19 | Read back: Crossref's record shows it | ● confirmed | 980c665ef007… |
4 entries · the last fingerprint 980c665ef0075bcf4f0ed4f46ae5241be05ea497a98216582ee3a49585666511 · the history as JSON, each entry with the fingerprint before it, to check them yourself.



